RA Effect on Cell Surface Molecules in Vivo

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 7, 2019

Primary Completion Date

May 8, 2019

Study Completion Date

May 8, 2019

Conditions
HIV Infections
Interventions
DRUG

Acitretin

Acitretin will be provided to participants in the formulation Soriatane. Soriatane doses are oral tablets taken daily by the participant. Participants will then receive 35mg of oral acitretin (Soriatane) daily for 8 weeks during the intervention phase. Participants will be asked to return two months after completion of the acitretin course for clinical follow-up and additional phlebotomy for laboratory testing.

All Listed Sponsors
lead

Ottawa Hospital Research Institute

OTHER